New Key Statistics Module, Z-Score and F-Score
OTCPK:TAIPY Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | -1,648.09 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,260.00 |
EPS (TTM) $ | 4,757,535.48 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -13.76 |
EV-to-EBITDA | -13.76 |
PEG | -- |
Shares Outstanding M | -- |
Net Margin (%) | 2.54 |
Operating Margin % | 5.80 |
Pre-tax Margin (%) | 5.23 |
Quick Ratio | 4.37 |
Current Ratio | 5.16 |
ROA % (ttm) | 0.83 |
ROE % (ttm) | 1.00 |
ROIC % (ttm) | 1.75 |
Dividend Yield % | 0.61 |
Altman Z-Score | 4.59 |
TAIPY Number of Guru Trades
TAIPY Volume of Guru Trades
Gurus Latest Trades with OTCPK:TAIPY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TAIPY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Taisho Pharmaceutical Holdings Co Ltd Insider Transactions
No Available Data
News about OTCPK:TAIPY
Total 0- 1